Report : Middle East and Africa Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Service (Hematology Products and Services, Hemostasis Products and Services, and Immunohematology Products and Services), Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, and Others), End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, and Research and Academic Institutes), and Country

According to a new market research study of ‘Middle East and Africa Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by product and service, application, and end-user’ the Middle East and Africa hematology analyzers and reagents market is expected to reach US$541.13 million in 2027 from US$ 340.66 million in 2019. The market is estimated to grow with a CAGR of 6.0% from 2020-2027. The report provides trends prevailing in the Middle East and Africa hematology analyzers and reagents market and the factors driving market along with those that act as hindrances.

Based on application, the hematology analyzers and reagents market is segmented into anemia, blood cancer, hemorrhagic conditions, infection related conditions, immune system related conditions, and others. The anemia segment held the largest share of the market in 2019, whereas the blood cancer segment is anticipated to register the highest CAGR in the market during the forecast period. The anemia market growth is expected due to the rising prevalence of anemia across the region. On the other hand, the blood cancer segment is expected to account for the fastest growth in the market during the forecast period 2020-2027 owing to the rapidly growing leukemia which may lead to symptoms such as symptoms such as fatigue, weight loss, frequent infections and easy bleeding or bruising. The treatment of leukemia is highly variable, however appropriate diagnosis and monitoring is the key and vital step towards deciding and keeping up with the therapy, due to which hematology analyzers play a key role in patients suffering with blood cancer.

The growth of this market is estimated to grow owing to key driving factors such as the increasing demand for organ transplantation and blood transfusion and a high rise in demand for point-of-care systems. However, the market growth is likely to be hindered owing to the concerns associated with products and high cost of hematology analyzers and reagents.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Danaher, BIO-RAD LABORATORIES INC. are among the leading companies operating in the Middle East and Africa hematology analyzers and reagents market. 

The report segments Middle East and Africa Hematology Analyzers and Reagents Market as Follows:

By Product and Service

  • Hematology Product and Services
    • Instruments
    • Reagents and Consumables
    • Services
  • Hemostasis Product and Services
    • Instruments
    • Reagents and Consumables
    • Services
  • Immunohematology Product and Services
    • Instruments
    • Reagents and Consumables
    • Services

By Application

  • Anemia
  • Blood Cancer
  • Haemorrhagic Conditions
  • Infection Related Conditions
  • Immune System Related Conditions
  • Others

By End User

  • Hospital Laboratories
  • Commercial Service Providers
  • Government Reference Laboratories
  • Research and Academic Institutes

By Country

  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com  

Download Free PDF Brochure